pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
mivocabtagene autoleucel · news · pharmadog
← back to mivocabtagene autoleucel
News mentioning mivocabtagene autoleucel
11
stories
7d
Kyverna abandons next-gen autoimmune CAR-T once touted as follow-up to miv-cel
fiercebiotech
17d
Cell therapy investment grows as safety events rankle Big Pharma's CAR T autoimmune push
biospace
Oct 5, 26
Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
biospace
Oct 5, 26
Weighing the risks of CAR T in autoimmune disease as Kyverna nears market
biospace
Sep 30, 26
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
biospace
Sep 24, 26
Kyverna steps closer to FDA-first CAR T for an autoimmune condition with durability data
biospace
Sep 23, 26
Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
fiercebiotech
Sep 2, 26
Autoimmune CAR-T faces tough questions after Novartis, Bristol Myers study halts
biopharma dive
Jul 29, 26
Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy
biospace
Jul 23, 26
Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapies
fiercebiotech
Jul 20, 26
How Kyverna rode CAR T’s autoimmune wave to the FDA’s door
biospace